Güncel Gönderiler: Araştırma Çıktıları | Wos

  • Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients 
    Bozdag, SC; Seval, GC; Hindilerden, IY; Hindilerden, F; Andic, N; Baydar, M; Kaynar, LA; Toprak, SK; Goksoy, HS; Aydin, BB; Demirci, U; Can, F; Ozkocaman, V; Gunduz, E; Guven, ZT; Ozkurt, ZN; Demircioglu, S; Beksac, M; Ince, I; Yilmaz, U; Kucukdiler, HE; Abishov, E; Yavuz, B; Atas, U; Mutlu, YG; Bas, V; Ozkalemkas, F; Teke, HU; Gursoy, V; Celik, S; Ciftciler, R; Yagci, M; Topcuoglu, P; Ceneli, O; Abbasov, H; Selim, C; Ar, MC; Yucel, OK; Sadri, S; Albayrak, C; Demir, AM; Guler, N; Keklik, M; Terzi, H; Dogan, A; Yegin, ZA; Yuksel, MK; Yavasoglu, I; Bekoz, HS; Aksu, T; Maral, S; Erol, V; Kaynar, L; Ilhan, O; Bolaman, AZ; Sevindik, OG; Akyay, A; Ozcan, M; Gurman, G; Cangul, SU; Yavuz, Y; Kucukkaya, RD; Ozsan, GH (2022)
    Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly ...
  • The success of the Cystic Fibrosis Registry of Turkey for improvement of 
    Asfuroglu, P; Eyuboglu, TS; Aslan, AT; Gursoy, TR; Emiralioglu, N; Yalcin, E; Kiper, N; Sen, V; Sen, HS; Altintas, DU; Ozcan, D; Kilinc, AA; Cokugras, H; Baskan, AK; Yazan, H; Erenberk, U; Dogan, G; Unal, G; Yilmaz, AI; Keskin, O; Arik, E; Kucukosmanoglu, E; Irmak, I; Damadoglu, E; Ozturk, GK; Gulen, F; Basaran, AE; Bingol, A; Cekic, S; Sapan, N; Kilic, G; Harmanci, K; Kose, M; Ozdemir, A; Tugcu, GD; Polat, SE; Hangul, M; Ozcan, G; Aydin, ZGG; Yuksel, H; Topal, E; Ozdogan, S; Caltepe, G; Suleyman, A; Can, D; Ekren, PK; Bal, CM; Kilic, M; Cinel, G; Cobanoglu, N; Pekcan, S; Cakir, E; Ozcelik, U; Dogru, D (2022)
    Background Cystic fibrosis (CF) registries play an essential role in improving disease outcomes of people with CF. This study aimed to evaluate the association of newly established CF registry system in Turkey on follow-up, ...
  • Frequency of Direct Oral Anticoagulants Usage in Acute Pulmonary 
    Tanriverdi, E; Tutar, N; Senturk, A; Bahadir, A; Aksel, N; Yetkin, NA; Karadeniz, G; Cetin, N; Tabaru, A; Yildirim, BZ; Sen, HS; Ozcelik, N; Ozsari, E; Uzer, F; Cicek, T; Esendagli, D; Hocanli, I; Kocak, ND; Tapan, U; Kurt, B; Arinc, S; Kavas, M; Sahin, F; Ergun, D; Ucar, EY; Kilic, T; Gulmez, I; Emre, JC; Dogan, D; Ozdemir, F; Duger, M; Alzafer, S; Yarar, E; Unat, DS; Salik, B (2022)
    Background: Direct oral anticoagulants (DOACs) have been used in acute pulmonary thromboembolism as an alternative to warfarin due to drug interactions, narrow therapeutic range, and necessary close International Normalized ...
  • The effect of COVID-19 on development of hair and nail disorders: a 
    Kutlu, O; Demircan, YT; Yildiz, K; Kalkan, G; Demirseren, DD; An, I; Oba, MC; Emre, S; Senel, E; Bilgili, SG; Savas, SE; Akturk, AS; Turkmen, D; Cakmak, SK; Kulakli, S; Demirbas, A; Altunisik, N; Cosansu, NC; Aksoy, GG; Tosun, M; Kurt, BO; Senturk, N; Sener, S; Ozden, HK; Temiz, SA; Atak, MF; Suslu, H; Oguz, ID; Kilic, S; Ustaoglu, E; Topal, IO; Akbulut, TO; Korkmaz, I; Kilic, A; Hizli, P; Kucuk, OS; Caytemel, C; Kara, RO; Koska, MC; Tatar, K; Dikicier, BS; Agirgol, S; Aksan, B; Karadag, AS
    Background A broad spectrum of skin diseases, including hair and nails, can be directly or indirectly triggered by COVID-19. It is aimed to examine the type and frequency of hair and nail disorders after COVID-19 infection. ...
  • CLINICAL COURSE OF ADOLESCENT ONSET ATYPICAL HEMOLYTIC UREMIC SYNDROME: 
    Celegen, K; Gulhan, B; Fidan, K; Yuksel, S; Yilmaz, N; Yilmaz, AC; Kilic, BD; Gokce, I; Tufan, AK; Kalyoncu, M; Nalcacioglu, H; Ozlu, SG; Sukur, EDK; Canpolat, N; Bayazit, AK; Koyun, M; Tabel, Y; Tulpar, S; Celakil, M; Bek, K; Zeybek, C; Duzova, A; Ozcakar, ZB; Topaloglu, R; Soylemezoglu, O; Ozaltin, F (2022)
  • Thalassemia-free and graft-versus-host-free survival: outcomes of 
    Yesilipek, MA; Uygun, V; Kupesiz, A; Karasu, G; Ozturk, G; Ertem, M; Sasmaz, I; Daloglu, H; Guler, E; Hazar, V; Fisgin, T; Sezgin, G; Kansoy, S; Kuskonmaz, B; Akinci, B; Ozbek, N; Ince, EU; Ozturkmen, S; Kupesiz, FT; Yalcin, K; Anak, S; Bozkurt, C; Karakukcu, M; Kupeli, S; Albayrak, D; Oniz, H; Aksoylar, S; Okur, FV; Albayrak, C; Yenigurbuz, FD; Bozkaya, IO; Ileri, T; Gursel, O; Karagun, BS; Kintrup, GT; Celen, S; Elli, M; Aksoy, BA; Yilmaz, E; Tanyeli, A; Akyol, ST; Sivi, ZO; Ozek, G; Uckan, D; Kartal, I; Atay, D; Akyay, A; Bilir, OA; Cakmakl, HF; Kurekci, E; Malbora, B; Akbayram, S; Demir, HA; Kilic, SC; Gunes, AM; Zengin, E; Ozmen, S; Antmen, AB (2022)
    We report the national data on the outcomes of hematopoietic stem cell transplantation (HSCT) for thalassemia major (TM) patients in Turkey on behalf of the Turkish Pediatric Stem Cell Transplantation Group. We retrospectively ...
  • The Turkish experience of COVID-19 infection in people with NMOSD and 
    Sen, S; Tuncer, A; Ozakbas, S; Uzunkopru, C; Baba, C; Demir, S; Beckmann, Y; Gumus, H; Arslan, G; Kilic, AK; Altintas, A; Yuceyar, N; Turan, OF; Tutuncu, M; Terzi, M; Acar, P; Bunul, SD; Balci, BP; Bir, LS; Koseoglu, M; Mungan, S; Gunduz, T; Dogan, IG; Kotan, D; Uygunoglu, U; Ekmekci, O; Demirkiran, M; Kamisli, O; Kabay, SC; Tamam, Y; Omerhoca, S; Sevim, S; Guler, S; Kurtuncu, M; Efendi, H; Karabudak, R; Siva, A (2022)
    Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and ...
  • Clinical findings of patients with cystic fibrosis according to newborn 
    Gursoy, TR; Aslan, AT; Asfuroglu, P; Eyuboglu, TS; Cakir, E; Cobanoglu, N; Pekcan, S; Cinel, G; Dogru, D; Ozcelik, U; Yalcin, E; Sen, V; Ercan, O; Kilinc, AA; Yazan, H; Altintas, DU; Ozturk, GK; Bingol, A; Sapan, N; Celebioglu, E; Tugcu, GD; Ozdemir, A; Harmanci, K; Kose, M; Emiralioglu, N; Tamay, Z; Yuksel, H; Ozcan, G; Topal, E; Can, D; Ekren, PK; Caltepe, G; Kilic, M; Ozdogan, S (2022)
    Background Cystic fibrosis (CF) is a lethal recessive genetic disease caused by loss of function associated with mutations in the CF trans-membrane conductance regulator. It is highly prevalent (approximately 1 in 3,500) ...
  • Demographic, clinical and laboratory characteristics of adult-onset 
    Aydin, Z; Yilmaz, M; Sipahioglu, M; Dervisoglu, E; Aydemir, N; Uzun, S; Istemihan, Z; Unsal, O; Tatar, E; Berktas, HB; Ozdemir, A; Sumnu, A; Kumru, G; Cetinkaya, H; Kazan, S; Kocyigit, I; Gokalp, C; Hasbal, B; Artan, AS; Ozelsancak, R; Taymez, D; Yadigar, S; Alagoz, S; Aslan, BB; Yaylaci, S; Jabrayilov, J; Turgutalp, K; Dursun, B; Sahin, G
    Purpose In our study, diagnostic and demographic characteristics of patients diagnosed with minimal change disease (MCD) by biopsy, clinical and laboratory findings in our country were investigated. Methods Data were ...
  • RESEARCH BURDEN OF INTERSTITIAL LUNG DISEASES IN TURKEY - RBILD 
    Aycicek, O; Cetinkaya, E; Ucsular, FD; Bayram, N; Senyigit, A; Aksel, N; Atilla, N; Sarioglu, N; Niksarlioglu, EY; Ilgazli, A; Kilic, T; Gunbatar, H; Cilekar, S; Ekici, A; Arinc, S; Bircan, HA; Duman, D; Dikis, OS; Yazici, O; Kansu, A; Tutar, N; Ozsari, E; Berk, S; Varol, Y; Erbaycu, AE; Sertogullarindan, BB; Cirak, AK; Cortuk, M; Karadeniz, G; Simsek, A; Sezgi, CC; Erel, F; Ciftci, T; Sunnetcioglu, AA; Ekici, MS; Gunay, E; Aca, M; Ozturk, O; Ogun, H; Acar, E; Dogan, OTOT; Alizoroglu, DD; Gezer, E; Ozlu, T (2022)
    Introduction: The aim of our study is to investigate the etiological distribution of ILD in Turkey by stratifying the epidemiological characteristics of ILD cases, and the direct cost of initial diagnosis of the diag-nosed ...
  • Real-life experience with maintenance chemotherapy plus biologics after 
    Artac, M; Cubukcu, E; Bozkurt, O; Bilici, A; Celik, S; Ozcelik, M; Oven, B; Simsek, E; Geredeli, C; Karaca, M; Cil, T; Harputluoglu, H; Endur, MSC; Turk, H; Kefeli, U; Alacacioglu, A; Tural, D; Sakin, A; Karadurmus, N; Cevik, D; Dane, F; Gumus, M (2022)
  • Research Burden of Interstitial Lung Diseases in Turkey-RBILD 
    Aycicek, O; Cetinkaya, E; Ucsular, FD; Bayram, N; Senyigit, A; Aksel, N; Atilla, N; Niksarlioglu, EY; Ilgazli, A; Kilic, T; Gunbatar, H; Cilekar, S; Ekici, A; Arinc, S; Bircan, HA; Duman, D; Dikis, OS; Yazici, O; Kansu, A; Tutar, N; Ozsari, E; Berk, S; Varol, Y; Erbaycu, AE; Cortuk, M; Karadeniz, G; Simsek, A; Sezgi, CC; Erel, F; Ciftci, T; Sunnetcioglu, A; Ekici, MS; Gunay, E; Agca, M; Ozturk, O; Ogun, H; Acar, E; Dogan, OT; Alizoroglu, D; Gezer, E; Ozlu, T (2022)
    Introduction:The aim of our study is to investigate the etiological distribution of ILD in Turkey by stratifying the epidemiological characteristics of ILD cases, and the direct cost of initial diagnosis of the diag-nosed ...
  • Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease 
    Karadag, S; Ozturk, S; Arici, M; Gorgulu, N; Akcali, E; Pembegul, I; Taymez, DG; Kazancioglu, R; Ayar, Y; Mutluay, R; Ozdemir, A; Aydin, Z; Bashan, Y; Alagoz, S; Yilmaz, F; Trabulus, S; Dirim, AB; Ozturk, I; Inci, A; Azak, A; Aktas, N; Kuzu, T; Dheir, H; Basturk, T; Ozler, TE; Dincer, MT; Turgutalp, K; Ulu, S; Gungor, O; Bakir, EA; Odabas, AR; Seyahi, N; Yildiz, A; Ates, K
    Purpose Coronavirus disease 2019 (COVID-19) has a higher mortality in the presence of chronic kidney disease (CKD). However, there has not been much research in the literature concerning the outcomes of CKD patients in the ...
  • Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter 
    Kahraman, FC; Erdogan, SS; Aktas, ND; Albayrak, H; Turkmen, D; Borlu, M; Arica, DA; Demirbas, A; Akbayrak, A; Ekinci, AP; Gokcek, GE; Celik, HA; Tasolar, MK; An, I; Temiz, SA; Hazinedar, E; Ayhan, E; Hizli, P; Solak, EO; Kilic, A; Yilmaz, E (2022)
    Objectives In this study covering all of Turkey, we aimed to define cutaneous and systemic adverse reactions in our patient population after COVID-19 vaccination with the Sinovac/CoronaVac (inactivated SARS-CoV-2) and ...
  • First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy 
    Isikdogan, A; Turk, H; Bilir, C; Sendur, M; Karabulut, B; Artac, M; Cicin, I; Geredeli, C; Alacacioglu, A; Kefeli, U; Harputluoglu, H; Bozkurt, O; Cubukcu, E; Tural, D; Sakin, A; Cil, T; Dane, F; Cevik, D; Arslan, C; Karadurmus, N; Gumus, M; Yalcin, S (2022)
  • Evaluation of Outcomes of Peritoneal Dialysis Patients in the 
    Ozturk, S; Gursu, M; Arici, M; Sahin, I; Eren, N; Yilmaz, M; Koyuncu, S; Sirali, SK; Ural, Z; Dursun, B; Yuksel, E; Uzun, S; Sipahi, S; Ahbap, E; Yazici, H; Altunoren, O; Tunca, O; Ayar, Y; Oguz, EG; Yilmaz, Z; Kahvecioglu, S; Asicioglu, E; Oruc, A; Ataman, R; Aydin, Z; Huddam, B; Dolarslan, ME; Azak, A; Bakirdogen, S; Yalcin, AU; Karadag, S; Ulu, MS; Gungor, O; Bakir, EA; Odabas, AR; Seyahi, N; Yildiz, A; Ates, K
    Introduction: There are not enough data on the post-CO-VID-19 period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare the clinical and laboratory data of PD patients after COVID-19 with a ...
  • The Real-World Experience With Single Agent Ibrutinib in 
    Akpinar, S; Dogu, MH; Celik, S; Ekinci, O; Hindilerden, IY; Dal, MS; Davulcu, EA; Tekinalp, A; Hindilerden, F; Ozcan, BG; Hacibekiroglu, T; Erkurt, MA; Bagci, M; Namdaroglu, S; Korkmaz, G; Bilgir, O; Cagliyan, GA; Ozturk, HBA; Serin, I; Tiryaki, TO; Ozatli, D; Korkmaz, S; Ulas, T; Eser, B; Turgut, B; Altuntas, F (2022)
    We evaluated the safety and efficacy of single-agent ibrutinib in 200 patients presenting with relapsed/refractory CLL in real-world settings. With an estimated median OS of 52 months, 146 patients (75%) achieved at least ...
  • A self-employed taxpayer experimental study on trust, power, and tax 
    Batrancea, LM; Nichita, A; De Agostini, R; Narcizo, FB; Forte, D; Mamede, SDN; Roux-Cesar, AM; Nedev, B; Vitek, L; Pantya, J; Salamzadeh, A; Nduka, EK; Kopyt, M; Pacheco, L; Maldonado, I; Isaga, N; Benk, S; Budak, T; Kudla, J (2022)
    The slippery slope framework explains tax compliance along two main dimensions, trust in authorities and power of authorities, which influence taxpayers' compliance attitudes. Through frequentist and Bayesian analyses, we ...
  • Real life efficacy and tolerability of Tenofovir alafenamde fumarate in 
    Gokcan, H; Yapali, S; Harputluoglu, M; Ellik, ZML; Gokcen, P; Adanir, H; Cosar, AM; Durak, S; Ari, D; Mehdiyev, S; Koc, ES; Guzelbulut, F; Alkim, H; Ekmen, N; Yildirim, AE; Unsal, Y; Teker, T; Etik, DO; Vatansever, S; Balaban, HY; Ozdil, K; Arslan, M; Kayhan, MA; Gunduz, F; Kiyici, M; Boyacioglu, S; Simsek, H; Tozun, N; Dincer, D; Idilman, R (2022)
  • Real-world treatment outcomes from nationwide Onco-colon Turkey registry 
    Yildirim, ME; Karaca, M; Artac, M; Cicin, I; Geredeli, C; Alacacioglu, A; Simsek, ET; Bilici, A; Harputluoglu, H; Ozcelik, M; Bozkurt, O; Yuksel, S; Tural, D; Sakin, A; Cil, T; Oven, BB; Dane, F; Cevik, D; Gumus, M; Isikdogan, A (2022)